REQUEST A DEMO
Total
USD $0.00
Search more companies

New Marketlink Pharmaceutical Corp. (Philippines)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: New Marketlink Pharmaceutical Corp. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

New Marketlink Pharmaceutical Corp. is an enterprise in Philippines, with the main office in Pasig City. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on November 14, 2006. 50 (estimated) employees currently work for New Marketlink Pharmaceutical Corp.. In 2023, the company reported a net sales revenue increase of 11%. There was a total growth of 1.51% in New Marketlink Pharmaceutical Corp.’s total assets over the same period. In 2023, New Marketlink Pharmaceutical Corp.’s net profit margin increased by 0.63%.

Headquarters
2Nd Floor Tao Corporate Center
Pasig City; Metro Manila; Postal Code: 1604

Contact Details: Purchase the New Marketlink Pharmaceutical Corp. report to view the information.

Basic Information
Total Employees:
Purchase the New Marketlink Pharmaceutical Corp. report to view the information.
Financial Auditors:
Purchase the New Marketlink Pharmaceutical Corp. report to view the information.
Incorporation Date:
November 14, 2006
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman and Director
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after New Marketlink Pharmaceutical Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
11%
Total Operating Revenue
11.7%
Operating Profit
22.42%
EBITDA
22.42%
Net Profit/Loss for the Period
20.01%
Total Assets
1.51%
Total Equity
-16.25%
Operating Profit Margin
1.46%
Net Profit Margin
0.63%
Return on Equity (ROE)
11.38%
Debt / Equity
15.38%
Quick Ratio
0.01%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?